The Utilization of Pupillometry in the Differential Diagnosis and Treatment of Psychotic and Behavioral Disorders

  • Leonard S. Rubin


A vast literature has accumulated over the last three decades implicating the central autonomic nervous system in the functional psychoses and other behavior disorders. Any attempt to crystallize conclusions from this prolific field of inquiry necessitates a categorization which hopefully possesses heuristic value. Laboratory parlance makes the distinction between “dry” and “wet” investigatory efforts. The first term generally refers to physiological investigations while the latter refers to chemical, pharmacological investigations of the juices of life-processes. Interestingly, these approaches to the problem of the role of autonomic mechanisms in psychoses have developed in a parallel fashion with little or no interaction. The following presentation attempts to converge these parallel modes of inquiry by demonstrating that pupillometry may serve as a useful transfer operator function.


Autonomic Dysfunction Behavioral Disorder Pupillary Dilatation Pupil Diameter Cold Pressor Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abood, L. G. The psychotomimetic glycolate esters and related drugs. In D. H. Efron (Ed.), Psychopharmacology. Public Health Service Publication 1836, United States Government Printing Office, Washington, D.C., 683–692.Google Scholar
  2. Alpert, M., Angrist, B., Diamond, F., and Gershon, S. Comparison of Ditran intoxication and acute alcohol psychoses. In W. Keup (Ed.), Origins and Mechanisms of Hallucinations. New York: Plenum Press, 245–259.Google Scholar
  3. Ashby, W. R., Collins, G. H., and Bassett, M. The effects of nicotinic acid, nicotinamide, and placebo on the chronic schizophrenic. Journal of Mental Science, 1960, 106(445), 1555–1559.PubMedGoogle Scholar
  4. Axelrod, J. Enzymatic formations of psychomimetic metabolites from normally occurring compounds. Science, 1961, 134(3475), 343.PubMedCrossRefGoogle Scholar
  5. Ban, T. A., and Lehmann, H.E. Nicotinic acid in the treatment of schizophrenia. Canadian Psychiatric Association Journal, 1970, 15, 499–500.PubMedGoogle Scholar
  6. Bliss, C. L., and Calhoun, D. W. An Outline of Biometry. New Haven: Yale Cooperative Corporation, 1954.Google Scholar
  7. Bonvallet, M., and Zbrozyna, A. Les commandes reticularies du systeme autonoma et en perticulier de l’innervation sympathique et parasympathique de la pupille. Archives Italiennes de Biologie, 1963, 101, 174–207.PubMedGoogle Scholar
  8. Brodie, B. B., and Shore, P. A. A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Annals of the New York Academy of Science, 1957, 66, 631–642.CrossRefGoogle Scholar
  9. Brune, G. G., and Himwich, H. E. Effects of methionine loading on the behavior of schizophrenic patients. Journal of Nervous and Mental Diseases, 1962, 134(5), 447–450.CrossRefGoogle Scholar
  10. Buck, C. W, Carscallen, H. B., and Hobbs, G.E. Temperature regulation in schizophrenia. Archives of Neurology and Psychiatry, 1950, 64, 828–842.PubMedCrossRefGoogle Scholar
  11. Catterson, A. G., Bennet, D. H., and Freudenberg, R. C. A survey of long stay schizophrenic patients. British Journal of Psychiatry, 1963, 109, 750–758.PubMedCrossRefGoogle Scholar
  12. Cerletti, A., and Rothlin, E. Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivates. Nature, 1955, 176, 785–786.PubMedCrossRefGoogle Scholar
  13. Cole, J. O. Therapeutic efficacy of antidepressant drugs: A review. Journal of the American Medical Association, 1964, 190, 448–455.PubMedGoogle Scholar
  14. Earle, A., and Earle, B. V. The blood pressure response to pain and emotion in schizophrenia. Journal of Nervous and Mental Diseases, 1955, 121, 132–139.CrossRefGoogle Scholar
  15. Englehart, E. Der humorale Wirkungsmechanismus der Okulomotoriusreizung. Archiv. für die Gesamte Physiologie des menschen und der tiere, 1931, 227, 220–234.CrossRefGoogle Scholar
  16. Eysenck, S. B. G. An experimental study of psychogalvanic reflex responses of normal, neurotic and psychotic subjects. Journal of Psychosomatic Research, 1956, 1, 258–272.PubMedCrossRefGoogle Scholar
  17. Feldberg, W., and Sherwood, S. L. Behavior of cats after intra-ventricular injections of eserine and DFP. Journal of Physiology, 1954, 125, 488–500.PubMedCentralPubMedGoogle Scholar
  18. Feldberg, W., and Vogt, M. Acetylcholine synthesis in different regions of the central nervous system. Journal of Physiology, 1948, 107, 372–381.PubMedCentralPubMedGoogle Scholar
  19. Forrer, G. R. Symposium on atropine toxicity therapy: history and future research. Journal of Nervous and Mental Diseases, 1956, 124, 256–259.CrossRefGoogle Scholar
  20. Forrest, F. M., Forrest, I. S., and Mason, A. S. Review of rapid urine tests for phenothiazine and related drugs. American Journal of Psychiatry, 1961, 118, 300–307.PubMedGoogle Scholar
  21. Freeman, H., Rodnick, E. H., Shakow, D., and Lebeaux, T. Carbohydrate tolerance of mentally disturbed soldiers. Psychosomatic Medicine, 1944, 6, 311–317.Google Scholar
  22. Friedhoff, A. J. A dopamine-cholinergic mechanism in production of psychotic symptoms. Biological Psychiatry, 1973, 6, 165–169.PubMedGoogle Scholar
  23. Frohlich, A., and Loewi, E. Uber eine Steigerung der adrenalin empfindlichkeit durch cocain. Archiv. für Experimentelle Pathologie und Pharmakologie, 1910, 62, 159–169.Google Scholar
  24. Funkenstein, D, H., Greenblatt, M., and Solomon, H.C. Autonomic nervous system changes following electric shock treatment. Journal of Nervous and Mental Diseases, 1948, 108, 409–422.CrossRefGoogle Scholar
  25. Funkenstein, D. H., Greenblatt, M., and Solomon, H.C. A test which predicts the clinical effects of electric shock treatment on schizophrenic patients. American Journal of Psychiatry, 1950, 106, 889–901.PubMedGoogle Scholar
  26. Gellhorn, E. Physiological Foundations of Neurology and Psychiatry, Minneapolis: University of Minnesota Press, 1956.Google Scholar
  27. Gellhorn, E, Autonomic Imbalance and the Hypothalamus. Minneapolis; University of Minnesota Press, 1957.Google Scholar
  28. Gellhorn, E., and Miller, A.D. Methacoline and noradrenaline tests. Archives of General Psychiatry, 1961, 4, 371–380.PubMedCrossRefGoogle Scholar
  29. Goodman, L. S., and Gilman, A. The Pharmacological Basis of Therapeutics (3rd ed.). New York: Macmillan Company, 1965, p. 460.Google Scholar
  30. Hess, W. R., and Koella, W. Experimentelle Studien uber die antagonistische Innervation. Zeitschrift für die Gesamte experimentelle medizin einschliesslich experimentelle chirurgie, 1950, 116, 431–443.CrossRefGoogle Scholar
  31. Hess, W. R., Koella, W., and Szabo, T. Experimentelle Studien uber die antagonistische Innervation. Zeitschrift für die Gesamte experimentelle medizin einchliesslich experimentelle chirurgie, 1950, 115, 481–490.CrossRefGoogle Scholar
  32. Hoffer, A., and Osmond, H. Treatment of schizophrenia with nicotinic acid: a 10 year follow-up. Acta Psychiatrica Scandinavica, 1964, 40(2), 171–189.PubMedCrossRefGoogle Scholar
  33. Hoffer, A., Osmond, H., and Smythies, J. Schizophrenia, new approach; result of year’s research. Journal of Mental Science, 1954., 100, 29–54.PubMedGoogle Scholar
  34. Hoskins, R. G. The Biology of Schizophrenia. New York: Norton, 1946.Google Scholar
  35. Igersheimer, W. W. Cold pressor test in functional psychotic synddromes. Archives of Neurology and Psychiatry, 1953, 70, 794–801PubMedCrossRefGoogle Scholar
  36. Kerbikov, O. V. Schizophrenia as a nosological problem. In, Symposium Schizophrenia. Vopr. Nozologii, Patogenaza, Klinikii, Anatomii, 1962, 1, 5-18.Google Scholar
  37. Klerman, G. L., Paykel, E. S., and Prusoff, B. In J. O. Cole, A. M. Freedman, and A. J. Friedhoff (Eds.), Psychopathology and Psychopharmacology. Baltimore: Johns Hopkins University Press, 1972.Google Scholar
  38. Kuntz, A. The Autonomie Nervous System. (4th Ed.). Philadelphia: Lea and Febinger, 1953.Google Scholar
  39. Loewenfeld, I. E. Mechanisms of reflex dilatation of the pupil: Historical review and experimental analysis. Documenta Ophthalmologica, 1958, 12, 185–448.CrossRefGoogle Scholar
  40. Lowenstein, O., and Loewenfeld, I. E. Role of sympathetic and para-sympathetic systems in reflex dilatation of the pupil. Archives of Neurology and Psychiatry, 1950, 64, 313–340.PubMedCrossRefGoogle Scholar
  41. Lowenstein, O., and Loewenfeld, I. E. Electronic pupillography: a new instrument and some clinical applications. Archives of Ophthalmology, 1958, 59, 352–363.PubMedCrossRefGoogle Scholar
  42. Malmo, R. B., and Shagass, C. Physiologic studies of reaction to stress in anxiety and early schizophrenia. Psychosomatic Medicine, 1949, 11, 9–24.PubMedGoogle Scholar
  43. Malmo, R. B., Shagass, C., and Smith, A. A. Responsiveness in chronic schizophrenia. Journal of Personality, 1951, 19, 359–375.PubMedCrossRefGoogle Scholar
  44. Mandali, A. J., and Morgan, M. Human brain enzyme makes indole hallucinogens. (Abstract). Proceedings of the 1970 American Psychological Association Meeting. 228.Google Scholar
  45. Mandelbrote, B., and Folkard, S. Some factors related to outcome and social adjustment in schizophrenia. Acta Psychiatrica Scandinavica, 1961, 37, 223–235.PubMedCrossRefGoogle Scholar
  46. Mendel, B., and Hawkins, R.D. Removal of acetylcholine by Cholinesterase injections and effect thereof on nerve impulse transmission. Journal of Neurophysiology, 1943, 6, 431–438.Google Scholar
  47. Osmond, H., and Smythies, J. Schizophrenia: a new approach. Journal of Mental Science, 1952, 98(411), 309–315.PubMedGoogle Scholar
  48. Pfeiffer, C. C., Jenney, E. H., Gallagher, W., Smith, R. P., Bevan, W., Killam, K. F., Killam, E. E., and Blackmore, W. Stimulant effect of 2-dimethyl aminoethanol. Science, 1957, 126, 610–611.PubMedCrossRefGoogle Scholar
  49. Pincus, G., and Elmadjian, F. The lymphocyte responses to heat stress in normal and psychotic subjects. Journal of Clinical Endocrinology and Metabolism, 1946, 6, 295–300.Google Scholar
  50. Polin, W., Cardon, P. V., and Kety, S. S. Effects of amino acid feedings in schizophrenic patients treated with iproniazid. Science, 1961, 133(3446), 104–105.CrossRefGoogle Scholar
  51. Poos, F. “Uber die Eignung der Pupillae als Testoojekt fur” pharmacologische Reaktionen und Pharmakodiagnostik an Auge. Ergebnisse der Physiologie, Biologische, Chemie, and Experimentellen Pharmakologie, 1939, 41, 883–916.Google Scholar
  52. Rubin, L. S. Acetylcholine hydrolysis in psychiatric patients. Science, 1958, 128, 254–255 (a).PubMedCrossRefGoogle Scholar
  53. Rubin, L. S. Cholinesterase activity. Science, 1958, 128, 1176–1178 (b).PubMedCrossRefGoogle Scholar
  54. Rubin, L.S. Pupillary reactivity as a measure of autonomic balance in the study of psychotic behavior: a rational approach to chemotherapy. Transactions of the New York Academy of Science, 1960, 22, 509–518 (a).CrossRefGoogle Scholar
  55. Rubin, L. S. Pupillary reactivity as a measure of adrenergic-cholinergic mechanisms in the study of psychotic behavior. Journal of Nervous and Mental Diseases, 1960, 130, 386–400 (b).CrossRefGoogle Scholar
  56. Rubin, L. S. Autonomic dysfunction in psychotic adults and autistic children. Archives of General Psychiatry, 1961, 7, 1–14 (a).CrossRefGoogle Scholar
  57. Rubin, L. S. Patterns of pupillary dilatation and constriction in psychotic adults and autistic children. Journal of Nervous and Mental Disease, 1961, 133, 130–142 (b).PubMedCrossRefGoogle Scholar
  58. Rubin, L. S. Autonomie dysfunction as a concomitant of neurotic behavior. Journal of Nervous and Mental Diseases, 1964. 138, 558–574.CrossRefGoogle Scholar
  59. Rubin, L. S. An organic basis for neurotic behavior. Psychosomatics, 1965, 6, 220–228 (a).PubMedCrossRefGoogle Scholar
  60. Rubin, L. S. Autonomic dysfunction in neurotic behavior Archives of General Psychiatry, 1965, 12, 572–585 (b).PubMedCrossRefGoogle Scholar
  61. Rubin, L. S., and Barry, T. J. The reactivity of the iris muscles as an index of autonomic dysfunction in schizophrenic remission. Journal of Nervous and Mental Diseases, 1972, 155, 265–276 (a).CrossRefGoogle Scholar
  62. Rubin, L. S., and Barry, T. J. The effect of the cold pressor test on pupillary reactivity of schizophrenics in remission. Biological Psychiatry, 1972, 5, 181–197 (b).PubMedGoogle Scholar
  63. Schildkraut, J. J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. American Journal of Psychiatry, 1965, 122, 509–522.PubMedGoogle Scholar
  64. Schildkraut, J. J., Schanberg, S. M., and Kopin, I. J. The effect of lithium on H3-norepinephrine metabolism in brain. Life Sciences, 1966, 5, 1479–1483.PubMedCrossRefGoogle Scholar
  65. Shattock, F. M. The somatic manifestations of schizophrenia: a clinical study of their significance. Journal of Mental Science, 1950, 98, 132–142.Google Scholar
  66. Shore, P. A. Possible mechanism of antidepressant action of Marsilid. Journal of Clinical and Experimental Psychopathology, 1958, 19, 56–60.PubMedGoogle Scholar
  67. Slater, E. A review of earlier evidence on genetic factors in schizophrenia. In D. Rosenthal and S. S. Kety (Eds.), Transmission of Schizophrenia. New York: Pergamon Press, 1968.Google Scholar
  68. Spector, S., Hirsch, C. W., and Brodie, B. B. Association of behavioral effects of pargyline, a non-hydracide MAO inhibitor with increase in brain norepinephrine. International Journal of Neuro-pharmacology, 1963, 2, 81–93.Google Scholar
  69. Stephens, D. A. Psychotoxic effects of benzhexol hydrochloride (Artane). British Journal of Psychiatry, 1967, 113, 213–218.PubMedCrossRefGoogle Scholar
  70. Truitt, E. B. Some pharmacologic correlations of the chemotherapy of mental disease. Journal of Nervous and Mental Diseases, 1958, 216, 184–210.CrossRefGoogle Scholar
  71. Vogt, M. The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. Journal of Physiology, 1954, 123, 451–481.PubMedCentralPubMedGoogle Scholar
  72. Weider, A., Brodman, K., Mittelman, B., Wechsler, D., and Wolff, H. G. The Cornell Index: a method for quickly assaying personality and psychosomatic disturbances, to be used as an adjunct to interview. Psychosomatic Medicine, 1946, 8, 411–413.PubMedGoogle Scholar
  73. Wing, J. K. Five years outcome in early schizophrenia. Proceedings of the Royal Society of Medicine, 1966, 59, 17–18.PubMedCentralPubMedGoogle Scholar
  74. Woolley, D. W., and Shaw, E. A biochemical and pharmacological suggestion about certain mental disorders. Science, 1954, 119, 587–588.Google Scholar
  75. Zbrozyna, A., and Bonvallet, M. Influence tonique inhibitrice du bulbe sur a’activite du noyau d’Edinger-Westphal. Archives Italiennes de Biologie, 1963, 101, 208–222.PubMedGoogle Scholar
  76. Zeller, E. A., Barsky, J., and Berman, E. R. Amine oxidases inhibition of monoamine oxidase by 1-isonicotiny1-2-isoprophlylhydrazine. Journal of Biological Chemistry, 1955, 214, 267–274.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1974

Authors and Affiliations

  • Leonard S. Rubin
    • 1
  1. 1.Eastern Pennsylvania Psychiatric InstitutePhiladelphiaUSA

Personalised recommendations